Kintor Pharmaceutical Limited
KNTPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $147 | $445 | $1 | $1 |
| Short-Term Investments | $1 | $10 | $0 | $0 |
| Receivables | $2 | $9 | $874 | $1,054 |
| Inventory | $2 | $0 | $604 | $351 |
| Other Curr. Assets | $19 | $8 | $29 | -$1,405 |
| Total Curr. Assets | $172 | $473 | $1,508 | $2 |
| Property Plant & Equip (Net) | $166 | $191 | $282 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $157 | $149 | $0 | $0 |
| Long-Term Investments | $17 | $8 | $0 | $0 |
| Tax Assets | $0 | $23 | $0 | $0 |
| Other NC Assets | $4 | $26 | $265 | $0 |
| Total NC Assets | $343 | $397 | $547 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $515 | $869 | $2,055 | $2,068 |
| Liabilities | – | – | – | – |
| Payables | $39 | $68 | $78 | $45 |
| Short-Term Debt | $113 | $118 | $103 | $9 |
| Tax Payable | $0 | $0 | $2 | $2 |
| Deferred Revenue | $0 | $0 | -$103 | -$9 |
| Other Curr. Liab. | $14 | $38 | $238 | $173 |
| Total Curr. Liab. | $167 | $225 | $318 | $220 |
| LT Debt | $20 | $136 | $183 | $150 |
| Deferred Rev, NC | $3 | $20 | $20 | $4 |
| Deferred Tax Liab, NC | $31 | $31 | $39 | $39 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $54 | $186 | $242 | $193 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $7 | $10 | $5 |
| Total Liabilities | $221 | $411 | $560 | $413 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$3,940 | -$3,785 | -$2,724 | -$1,769 |
| AOCI | $24 | $61 | $115 | $65 |
| Other Equity | $4,210 | $4,182 | $4,104 | $3,359 |
| Total Equity | $294 | $458 | $1,495 | $1,655 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $515 | $869 | $2,055 | $2,068 |
| Net Debt | -$14 | -$192 | $286 | $159 |